Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-30

FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

View source ↗

Summary

FDA approved a supplemental application for DATSCAN (IOFLUPANE I-123) by Medi-Physics Inc. dba GE Healthcare, indicating an update to the labeling/indication fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaTscan (ioflupane)

Snippet

SUPPL AP for DATSCAN (IOFLUPANE I-123)